Search Result "second-line ART"
Second-Line Antiretroviral Therapy for HIV-Infected Children in Resource Limited Settings
Journal: Current Pediatric Reviews
Volume: 7 Issue: 3 Year: 2011 Page: 180-187
Author(s): Linda Aurpibul, Thanyawee Puthanakit
HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Crosssectional Design
Journal: Current HIV Research
Volume: 15 Issue: 1 Year: 2017 Page: 66-73
Author(s): Aubin J. Nanfack,Desire Takou,Joseph Fokam,Romina Salpini,Maria M. Santoro,Giulia Cappelli,Martin Baane,Suzie M. Tetang,Josef Eberle,Lutz Gurtler,Francesca Ceccherini-Silberstein,Judith N. Torimiro,Vittorio Colizzi,Carlo-Federico Perno,Alexis Ndjolo
Effectors of Hyperlipidemia Among Patients with HIV/AIDS TakingSecond-line Antiretroviral Therapy Based on Registry Data
Journal: Current HIV Research
Volume: 20 Issue: 5 Year: 2022 Page: 373-379
Author(s):
Immunological and Virological Outcomes of Patients Switched from LPV/r to ATV/r-Containing Second- Line Regimens
Journal: Current HIV Research
Volume: 13 Issue: 3 Year: 2015 Page: 176-183
Author(s): A.S. Akanmu,T. Adeyemo,F. Lesi,F.O. Bello,K. Okwuegbuna,K. Oloko,A. Awolola,F.T. Ogunsola,P. Okonkwo,P.J. Kanki
Ecto-ADP-Ribosyltransferases (ARTs): Emerging Actors in Cell Communication and Signaling
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 7 Year: 2004 Page: 857-872
Author(s): Michel Seman, Sahil Adriouch, Friedrich Haag, Friedrich Koch-Nolte
The Art of the Post-Modern Era and the Da Vinci Code
Ebook: Architecture in Contemporary Literature
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815165166123010016
Mortality Risk Factors Among People Living with HIV ReceivingSecond-line Antiretroviral Therapy in Rural China
Journal: Current HIV Research
Volume: 22 Issue: 2 Year: 2024 Page: 100-108
Author(s):
Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 2 Year: 2010 Page: 96-114
Author(s): Veronique Dartois, Clifton E. Barry
Current State of the Art of New Tubulin Inhibitors in the Clinic
Journal: Current Clinical Pharmacology
Volume: 1 Issue: 1 Year: 2006 Page: 57-70
Author(s): Isa E.L.M. Kuppens
Low-Abundance Resistant Mutations in HIV-1 Subtype C Antiretroviral Therapy-Naive Individuals as Revealed by Pyrosequencing
Journal: Current HIV Research
Volume: 11 Issue: 1 Year: 2013 Page: 43-49
Author(s): Sandra Gonzalez,Damien C. Tully,Clement Gondwe,Charles Wood